[Federal Register Volume 77, Number 111 (Friday, June 8, 2012)]
[Notices]
[Page 34073]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-13917]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration; 
Pharmagra Labs, Inc.

    By Notice dated January 30, 2012, and published in the Federal 
Register on February 6, 2012, 77 FR 5846, Pharmagra Labs Inc., 158 
McLean Road, Brevard, North Carolina 28712, made application by renewal 
to the Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of Pentobarbital (2270), a basic class of controlled 
substance in schedule II.
    The company plans to manufacture the listed substance for 
analytical research and clinical trials.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a), and determined that the registration 
of Pharmagra Labs, Inc. to manufacture the listed basic class of 
controlled substance is consistent with the public interest at this 
time. DEA has investigated Pharmagra Labs, Inc. to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above named company is granted registration as a bulk 
manufacturer of the basic class of controlled substance listed.

     Dated: May 31, 2012.
 Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-13917 Filed 6-7-12; 8:45 am]
BILLING CODE 4410-09-P